Biochemistry · Nucleotide Metabolism and Disorders (Purine/Pyrimidine, Gout, Lesch-Nyhan, ADA-SCID)

A 55-year-old man with chronic tophaceous gout is started on allopurinol. The drug works by inhibiting xanthine oxidase. Which statement about the resulting metabolic change is CORRECT?

  • A Orotic acid excretion increases as a compensatory response
  • B Hypoxanthine and xanthine replace uric acid and are more soluble in urine
  • C PRPP levels fall immediately due to increased salvage of purines
  • D Serum adenosine rises, causing cardiac arrhythmias
Correct answer: B. Hypoxanthine and xanthine replace uric acid and are more soluble in urine

Explanation

Allopurinol is an analog of hypoxanthine that is converted to alloxanthine (oxipurinol) by xanthine oxidase, causing suicide inhibition of the enzyme. This blocks the final steps of uric acid synthesis, causing accumulation of hypoxanthine and xanthine instead. Both are significantly more water-soluble than uric acid (solubility ~200 mg/L vs ~65 mg/L for urate at pH 7), reducing crystallization. PRPP depletion is a secondary long-term effect; orotic acid elevation occurs with UMPS deficiency.

Reference: Harper's Illustrated Biochemistry, 32nd ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Nucleotide Metabolism and Disorders (Purine/Pyrimidine, Gout, Lesch-Nyhan, ADA-SCID) MCQs

See all Nucleotide Metabolism and Disorders (Purine/Pyrimidine, Gout, Lesch-Nyhan, ADA-SCID) MCQs →